Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. - Wikidata - awgldk - TriplyDB

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

http://www.wikidata.org/entity/Q33373891

about

Pathophysiology of thrombotic thrombocytopenic purpura Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis.Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia.Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy.A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus: Diagnostic Utility of ADAMTS-13 Activity.Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality.Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation von Willebrand factor is a cofactor in complement regulation.Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms.THE ENDOTHELIUM IN SEPSIS.Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis.ADAMTS13: a new link between thrombosis and inflammation.Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study Decreased ADAMTS-13 level is related to inflammation factors and risk stratification of acute lymphoblastic leukemia patients.Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange.SNPs in ADAMTS13.Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.Histones stimulate von Willebrand factor release in vitro and in vivo.Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease.TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease

P2860

Q24614117-0860C1A2-C241-4895-8543-F8EA8DC5C73D Q30504401-EFDD2DCA-C0EC-4F96-84E6-ED13D97FE3C8 Q30511960-F2493FC0-816E-4399-82E6-98AF15B15187 Q30543370-591D4998-9A6D-4BE5-94C3-5C32FBC65D26 Q33376071-0B9F931F-B672-47C4-BE2D-B72D6DA85595 Q33377815-6E9E9298-5622-42BE-8FAF-BDDCAA5B1B95 Q33381217-F0BB37C3-D8EE-421C-BABD-F11985BF6BA5 Q33393302-C9C94EC7-63F3-4D75-9AC5-FEAB6EE9AD4C Q33394765-5C2C4E3C-790E-4569-9887-80F652D02CD1 Q33396306-532911A0-75DF-4A43-B1D2-A8DAAA5FD16B Q33406706-55F3F335-E554-4AC1-A29C-6772445180AB Q33410457-89070713-0AE8-46F5-85DE-A363B817045C Q33410829-9BC2868B-F3D9-4CF8-8BBB-ECDBA096E7A2 Q33419324-44AA53C5-CDC4-4109-A22F-B9397764FD3C Q33419829-4AB8B44A-5C87-4B33-842C-7743D4BCB8CA Q33426245-F4CFCCF0-F9E3-40EE-B661-213F169306CE Q33434503-266FFDEB-082C-41A7-9D81-9291ADFA9477 Q33440172-75FC467D-FB95-430A-A66F-50B4665BD969 Q33441000-C10BE03A-EF66-4FBA-BEF5-FF77E5562454 Q33608705-0F3072A6-4431-49D8-B210-ED6912CB9641 Q33751764-06AABF1E-B7C3-4D43-85E4-E06F6AE9C3E9 Q35056291-54FD74E9-9CAF-407C-BAEC-DF0D05E70F88 Q35121231-ADB82554-FCDE-49F9-AB9F-6B48DBCF0B27 Q35124387-4040A3E1-6533-4DCF-8232-4BC4E12C18BA Q35922159-012A609F-5285-4189-8EDE-1CEF8C7C360B Q36224102-34330776-BCC1-4368-99DC-CED760D5C7BB Q36838015-10434DC3-FEA1-4155-B2F6-86B2E2F13C96 Q36853418-8F4B5B01-88C1-4143-A6A1-9ADF2723392C Q36990628-19334AAE-3328-4947-A711-B6FAAAF92598 Q37656360-26BBD309-5978-4B58-9E9F-061E9FCDC456 Q37904925-0CBCD0FE-0F42-4809-B320-87F8EED52945 Q37917779-ABF667BF-6819-4F22-91C9-6A6F02310E58 Q41994903-4554F958-0471-42C0-B3FF-5EF42B25BB13 Q42399833-5D7B71EC-B906-4206-97C0-8D7FAF4D3489 Q47244753-25FE18AF-3217-407F-961A-4006FC0B8041 Q58788522-5C8B3034-6ED8-482E-8AB7-3524BE005205

P2860

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

http://www.wikidata.org/entity/Q33373891

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@ast

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@en

type

label

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@ast

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@en

prefLabel

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@ast

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@en

P1433

Q33373891-20F1A3CE-7900-42E7-A18A-4EC99FFA89DE

P1476

Q33373891-D9E3F3CC-B39F-46D4-BC58-FDC3A1F4CC9F

P2093

Q33373891-1C4193BB-AB95-4DE3-938F-C2E3B7815F84

Q33373891-22325BE9-DBE7-454B-9652-693E35DA3B90

Q33373891-337C0469-B462-4CC6-A59C-E4977E29ED5B

Q33373891-4CB636DC-E295-4227-92C7-905D1AE87135

Q33373891-4F5313B7-5A73-490A-840C-3BF738404218

Q33373891-825AD31C-6867-4EB5-8C77-33D062FEE3E5

Q33373891-9D199C9F-A38F-45D8-ABA8-019C0C561B7E

Q33373891-B6634850-54E7-4814-AAEA-1A6E3FC511EA

Q33373891-E9887B15-D721-4922-A6C2-AB09514C7CBD

P304

Q33373891-9CD0FFB9-2840-43A8-8949-66CE39DEAFA5

P31

Q33373891-9BD19B90-A615-48F1-AADF-D69B77B3BED1

P356

Q33373891-671795B4-28EE-4D65-BDB1-C59B0DAE9AF0

P433

Q33373891-2164F008-C046-4917-AA6A-0299D80521FD

P478

Q33373891-BBD7BE6D-86A5-475C-8C9B-A57CD688C150

P577

Q33373891-A3E09BBA-976D-457C-BD67-5117A68405DE

P698

Q33373891-A0231DAF-488E-42D6-B21F-E4396C997FFD

P921

Q33373891-4972A3A4-1ECA-4D88-B0E4-583E3B5A0656

P356

P1433

P1476

Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

@en

P2093

Angela L Bergeron

http://www.w3.org/2001/XMLSchema#string

Anne Liu

http://www.w3.org/2001/XMLSchema#string

Chalmette Ball

http://www.w3.org/2001/XMLSchema#string

Hiuwan Choi

http://www.w3.org/2001/XMLSchema#string

Jing-Fei Dong

http://www.w3.org/2001/XMLSchema#string

Khatira Aboulfatova

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Trung C Nguyen

http://www.w3.org/2001/XMLSchema#string

William S May

http://www.w3.org/2001/XMLSchema#string

P304

121-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.10262

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17229645

http://www.w3.org/2001/XMLSchema#string

P921